NCT01814319View on ClinicalTrials.gov

Repurposing Probenecid as a Positive Inotrope for the Treatment of Heart Failure

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Systolic Heart Failure
Interventions
DRUG

Probenecid 1 gr oral twice daily

Probenecid 1 gram oral twice daily

DRUG

Placebo

Matching placebo oral twice daily

Trial Locations (1)

45267

University of Cincinnati, Cincinnati

All Listed Sponsors
lead

University of Cincinnati

OTHER

NCT01814319 - Repurposing Probenecid as a Positive Inotrope for the Treatment of Heart Failure | Biotech Hunter | Biotech Hunter